9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利

2020-10-16 MedSci原创 MedSci原创

据Worldometers实时统计数据显示，截至北京时间10月16日07时30分，全球新冠肺炎（COVID-19）确诊病例达3914万例，新增391,652例至39,144,675例，再创新增记录。死

据Worldometers实时统计数据显示，截至北京时间10月16日07时30分，全球新冠肺炎（COVID-19）确诊病例达3914万例，新增391,652例至39,144,675例，再创新增记录。死亡病例达110万例，新增5,981例至1,102,299例，康复29,355,315例，活动病例8,616,893例，其中重症危重症为70,870例。全球确诊病例超过10万例的国家增至44个，瑞典为最新一个超过10万的国家。此外，危地马拉、葡萄牙、哥斯达黎加和日本的确诊病例已经超过9万。昨日报道：10月15日全球新冠肺炎（COVID-19）疫情简报，确诊超3872万，群体免疫做法再现争议

世界卫生组织实时统计数据显示，截至欧洲中部时间10月15日15时53分（北京时间21时53分），全球报告新冠肺炎确诊病例较前一日增加336515例，全球确诊病例超3839万例，达38394169例；全球报告新冠肺炎死亡病例超108.9万，达1089047例，较前一日增加5297例。

英军核潜艇到访美国后35人感染新冠艇员曾违规前往脱衣舞俱乐部

据美国海军研究学会（USNI）网站10月14日报道，一名美国官员透露，在对美国海军东海岸战略导弹核潜艇中心进行港口访问之后，英国皇家海军的“警惕”号战略导弹核潜艇上35多名被检测出感染新冠病毒。
这名美国官员证实了此前英国媒体的报道，即潜艇艇员违反了为防止潜艇上出现疫情的隔离规定。此前英国媒体报道称，潜艇艇员离开了位于美国乔治亚州国王湾的海军潜艇基地，曾到过200英里（约322公里）之外的佛罗里达州的可可海滩（佛罗里达州著名景点）。
而另据英国《镜报》14日的报道，该潜艇停靠在佛罗里达州后，35名水兵前往了位于佛罗里达州和佐治亚州和的酒吧及脱衣舞俱乐部，随后相继新冠检测呈阳性。

礼来公司的LY-CoV555抗体疗法也暂停试验

美国制药企业礼来公司13日宣布，因潜在安全原因暂停一项新冠抗体疗法的临床试验。礼来公司的LY-CoV555抗体疗法3期临床试验于8月初启动。这种抗体是一种针对新冠病毒刺突蛋白的单克隆抗体，从美国一名早期新冠康复患者的血液样本中分离而来。礼来公司没有透露暂停试验的具体原因，表示试验的独立数据安全监控委员会建议暂停继续招募试验参与者。

拜登竞选阵营称有两人新冠检测呈阳性

拜登竞选阵营称有两人新冠检测呈阳性。美国民主党副总统候选人哈里斯助手新冠检测呈阳性，此前其助手新冠检测呈阳性。拜登竞选团队经理表示，哈里斯没有被要求隔离，但出于谨慎起见取消了整个周日的行程，将于10月19日重回竞选活动，维持虚拟活动日程安排。

全球第五例！美国首例！25岁男子两次感染新冠，第二次病情加重

北京时间10月13日，发表在《Lancet Infectious Diseases（柳叶刀传染病）》上的一项新研究显示，美国内华达州一名25岁的男子先后两次感染新冠病毒，而且，在第二次感染后病情加重。

这是美国首例重新感染新冠病毒的确诊病例，也是全球报告的第五个已知病例。

这名25岁男子是美国内华达州Washoe县的居民，第一次感染是在2020年4月的社区检测中证实；第二次是出现症状后于2020年5月底至2020年6月在医院确诊。

这些发现表明，该患者在两次不同的情况下被遗传上不同的新冠病毒感染了两次。因此，以前暴露过新冠病毒的人不能保证完全免疫。无论以前是否诊断为新冠肺炎，都应该采取相同的预防措施，以避免感染新冠病毒。”

《柳叶刀》杂志称，该患者已提供书面同意发表该报告，而内华达大学Reno机构审查委员会则放弃伦理许可。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (10)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 志明

今年过年，为了防范第二波疫情，会不会延长假期呢？#新冠肺炎#

121 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-17 lilianxiang

#创新#

72 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-17 lqvr

#研发#

51 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-17 huirong

#药物研发#

66 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 ms4000000799709505

注意预防

106 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 公卫新人

新冠肺炎，疫情何时才能消失

60 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 lovetcm

疫苗，中和抗体都不安全？现在看来#雷尼替丁##枸橼酸铋#最强？甚至比#瑞德西韦#还有效！#新冠肺炎#

254 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 ms5000001082989414

新的一轮感觉要来了

121 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 神盾医疗局局长Jack

#新冠肺炎#加剧

112 0
[GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年，为了防范第二波疫情，会不会延长假期呢？<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗，中和抗体都不安全？现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强？甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效！<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 内科

看过

85 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

预防医学

9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利

相关资讯

科室

工具

服务